Doctor.One

What Doctor.One does

Doctor.One is a Polish digital health company, founded in 2021 and headquartered in Warsaw, that operates an asynchronous chronic-care communication platform linking treating healthcare professionals with their chronic-disease patients between visits. The product consists of two mobile applications — a patient-facing Doctor.One Patient App and a Doctor.One HCP App for clinicians — built around secure in-app messaging, structured care pathways with timed educational guidance, photo and document exchange, prescription issuance, and care-team routing where non-medical questions are triaged to nurses and only medical issues are escalated to physicians. The company operates a dual-entity structure (Doctor One Sp. z o.o. as the technology entity and Doctor One Polska Sp. z o.o. as a registered Polish medical entity) and holds ISO 27001 and GDPR certifications, holding all patient data inside the EU.

The platform sells through three revenue streams: a patient-paid subscription of 59 PLN per month for ongoing care-plan access (with physicians individually setting prices and a free basic chat tier available), enterprise white-label platform licensing to pharmaceutical companies running patient support programs — visible deployments include Novartis (multiple sclerosis), Novo Nordisk (chronic care including Ozempic-supported therapy), Merck, and AstraZeneca — and direct B2B hospital partnerships (for example UCK, UCKWUM, Szpital Joannitas) for post-discharge continuity of care. Distribution combines enterprise field sales into pharma and hospital accounts with product-led growth on the consumer side, where physicians invite existing patients onto the platform and adoption spreads via trusted clinician-patient relationships.

As of the most recent disclosed metrics Doctor.One reports approximately 3,815-4,000+ active healthcare professionals across 20 specialties, 15,000+ patients, and 443,432+ documented micro-interactions, against a self-reported base of 11-50 employees. The company has raised €4.44 million in cumulative venture funding (a €440K pre-seed from Movens Capital in December 2021 and a €4 million seed led by YZR Capital in September 2025), acquired DoctorDok in April 2025, and announced a planned geographic expansion from Poland into Germany, Spain, and the UK.

Name

Doctor.One

Legal name

Doctor One Sp. z o.o.

Website

https://doctor.one

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

Doctor.One is a Warsaw-based digital health platform that enables asynchronous, secure messaging and care-pathway management between treating physicians and chronic-disease patients, serving hospitals, pharmaceutical companies running patient support programs, and individual healthcare professionals across Poland and expanding into Germany, Spain, and the UK.

Ownership category

akta.pro rank

Product category

Digital chronic care communication platform

NAICS

Offices of Physicians (62111)

SIC

Services-Health Services (8000)

akta.pro primary industry

Healthcare On‑Demand Platforms (Telehealth, Home Care, Nursing) (BPAMAHAH)

akta.pro secondary industry

Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology) (HLALABAD)

Keywords

• Chronic care platform
• Asynchronous patient communication
• Digital health messaging
• Patient support programs
• Care pathway management

Headquarters

HQ city

Warsaw

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Subscription - Care Plans: Patients pay monthly subscription fees (59 PLN) to their doctors for ongoing care access including messaging, prescriptions, and medical documentation
2. B2B Platform Licensing: Pharmaceutical companies (Novartis, Novo Nordisk, Merck, AstraZeneca) pay for white-label platform deployment in patient support programs
3. Hospital Partnerships: Hospitals pay for continuity of care platform enabling post-discharge communication with patients

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

Core offering

Doctor.One is a digital chronic care platform that enables continuous, asynchronous communication between healthcare professionals and chronic disease patients through mobile apps. The platform includes secure messaging, care pathway automation, prescription issuance, and care team coordination, and is offered both as a white-label solution for pharmaceutical company patient support programs and as a subscribed continuity-of-care service for hospitals and individual clinicians.

Product overview

Doctor.One is a digital chronic care platform consisting of two mobile applications (Doctor.One Patient App for patients and Doctor.One HCP App for healthcare professionals) and a centralized management platform. The system enables asynchronous, secure communication between treating healthcare professionals and chronic disease patients, with care pathway automation, care team coordination, and prescription management integrated into a unified experience. The platform is offered to hospitals, pharmaceutical companies, and healthcare professionals serving chronic patients.

Differentiator

Problem solved

Functional benefit

Products and services

• Doctor.One Patient App

Quantifiable outcome

• 88% of patients better understand their condition and therapy
• +4 more outcomes

Named customers9 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Partnerships

Seven partnerships are on record, tiered flagship, core and minor.

• NovartisflagshipStrategic or Co-development PartnerCollaboration on multiple sclerosis patient care programs; 9 out of 10 physicians in the Novartis MS program recommended Doctor.One to colleagues. Includes patient support program deployment.
• Novo NordiskcoreStrategic or Co-development PartnerDigital chronic care platform partnership supporting patients on Ozempic and other therapies requiring ongoing medical supervision.
• MerckcoreStrategic or Co-development PartnerPatient support program collaboration for chronic disease management.
• AstraZenecacoreStrategic or Co-development PartnerCollaboration on patient engagement and chronic care programs.
• Uniwersyteckie Centrum Kliniczne (UCK)coreStrategic or Co-development PartnerMajor Polish hospital using Doctor.One platform for patient care continuity programs.
• Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego (UCKWUM)coreStrategic or Co-development PartnerAcademic medical center partnership for digital health innovation.
• Szpital JoannitasminorStrategic or Co-development PartnerRegional hospital using the platform for patient communication.

Scale indicators11 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Klara: Klara provides secure patient messaging and communication workflows for medical practices and specialty groups. It is a direct competitor to Doctor.One on asynchronous physician-patient communication in chronic care.
• Doctolib: European healthcare platform offering appointment booking, teleconsultation, and patient communication across France, Germany, Italy, and Spain. Comparable to Doctor.One as a pan-European physician-patient communication and telehealth platform.
• Kry (Livi): European digital healthcare provider offering video consultations and asynchronous care across Sweden, Norway, France, Germany, and the UK. Comparable to Doctor.One in delivering remote chronic and primary care through a digital-first patient experience.
• Doximity: US-based physician communication platform with secure messaging, telehealth, and workflow tools. Comparable to Doctor.One as a physician-facing communication and care-coordination platform, though US-focused.
• Vivify Health: Remote patient monitoring and chronic care management platform connecting patients with their care teams. Comparable to Doctor.One in extending physician-led care beyond the visit for chronic populations.
• Welldoc: Digital chronic care platform focused on diabetes, hypertension, and behavioral health, often deployed through payer and pharma partnerships. Comparable to Doctor.One in chronic-condition management and pharma-sponsored deployment models.
• Omada Health: Digital therapeutic platform for chronic conditions (diabetes, hypertension, musculoskeletal) sold to payers, employers, and pharmacy partners. Comparable to Doctor.One in chronic-condition virtual care with enterprise go-to-market.
• Medisafe: Digital medication adherence platform frequently deployed through pharma patient support programs. Comparable to Doctor.One as a pharma-sponsored patient engagement platform for chronic and specialty therapy adherence.

Broad incumbents

• Teladoc Health: Global incumbent in virtual care spanning general, chronic, and mental health. Comparable to Doctor.One as a chronic and primary care telehealth player, but operates at much larger scale and across many more geographies.
• Amwell: Enterprise telehealth platform serving health systems, payers, and pharma with virtual visit and care management capabilities. Comparable to Doctor.One as a B2B virtual care vendor to hospitals and pharmaceutical companies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/doctoronepl
• LinkedInlinkedin.com/company/doctorone
• Instagraminstagram.com/doctor.one_app?igshid=MTZ5NXIxNzgzZ2Jsbg==

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds4 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Doctor.One